Tax W JM , Tam boer W PM , M ensink EJBM , K oene R A P. Analysis at the D N A Level o f H um an FC7 R II Isoforms in Relation to the Polym orphic Binding o f M urine IgG 2b to H u m an B Cells. Scand J Im m unol 1996;44:571-577 Three classes o f hum an leucocyte FC7 receptors (I1FC7 R) have been identified so far: I1FC7 R I, hFc7 R II, and I1FC7RIIL Previous studies have dem onstrated th a t genetically determ ined differences between individuals exist both with respect to the binding of m urine Ig G l (m lg G l) to h F c7 receptors, and with respect to the binding of m urine IgG2b (mIgG2b). The polym orphism in binding o f m lg G l could be ascribed to I1FC7 R IIA , an isoform of UFbyRIL The authors have now investigated w hether one o f the isoforms of I1FC7 R II is also responsible for the polym orphism in binding o f m IgG 2b. In these studies the authors used EBV -transform ed hum an B cells th at dem onstrated either binding or no binding of m IgG2b in EA-rosetting assays. m R N A obtained from these cells was amplified by reverse transcriptase and polymerase chain reaction (RT-PCR). H ybridization experiments with the R T -P C R products revealed that the h F c7 RIIB but not the hFc7 R IIA isoform was present in these cells. D N A sequencing further dem onstrated that the nucleotide sequence of both the extracellular p a rt an d the cytoplasm ic moiety of I1FC7 RIIB was identical for all individuals tested, regardless o f their ability to bind m IgG 2b. These findings indicate that the polym orphic binding o f m IgG 2b cannot be ascribed to one o f the isoforms of I1FC7 RIL Since I1FC7 RI and h F c7 R III are not present on the cell surface of these cells, the authors conclude th at an Fc receptor different from the know n I1 FC7 receptors m ust be responsible for the polymorphic binding of m IgG 2b. These data further expand the com plexity of I1 FC7 R.
W hen murine monoclonal antibodies (MoAb) are used for immunotherapy, their biological effects and clinical sideeffects are strongly influenced by their interaction (or lack o f it) with human FC7 receptors (hFc7 R). This has been demonstrated both in tumour therapy [1 , 2] and in immuno suppressive therapy after organ transplantation [3, 4] . Three classes of human leucocyte FC7R have been identified at the molecular level: hFc7RI, hFc7RII, and hFc7RIII [5, 6] . M urine IgG2a can bind to I1FC7 RI. m lgG l can bind to an isoform of I1FC7 RII, but this binding is polymorphic: 70% of Caucasians are m lgG l 'high-responder5 (HR) whereas 30% are m lgG l low-responder (LR) [7, 8] .
We have described a similar polymorphism with respect to the binding of mIgG2b to human mononuclear cells. T cell proliferation was induced by mIgG2b anti-CD 3 M oAb only when accessory cells were present that could bind mIgG2b. In this way m IgG 2b-H R and mIgG2b-LR individuals could be defined [9] , The percentage of m IgG 2b-H R is much lower (3%) than the percentage of m lg G l-H R (70%)* It is impor tant to note that mIgG2b anti-CD 3 M oA b (in contrast to m lgG l) was still mitogenic after the complete removal of monocytes from the mononuclear cells of m IgG2b-HR indi viduals [9] , indicating that other cells than monocytes (pre sumably B cells) can also provide accessory function. The mIgG2b polymorphism could also be demonstrated in EBVtransformed B cells [9] [10] [11] . The I1FC7 R responsible for the polymorphic binding of mIgG2b has not yet been identified. Since I1FC7RI and hFc7RIII are not present on EBV-transformed B cells that can bind mIgG2b [9] , hFc7 RII appeared to be the most likely candidate, as was also suggested by studies with polymeric mIgG2b [12] .
I1FC7RII occurs in several isoforms, that are encoded by three genes: hFc7 RIIA, I1FC7 RIIB, and I1FC7RIIC. The transcripts from I1FC7 RIIA (hFc7RIIa) and I1FC7RIIB (hFc7RIIb) are highly homologous in the extracellular and transmembrane regions, but differ in the cytoplasmic region [13] . The transcript of FC7 RIIC (hFc7 RIIc) is identical to hFc7RIIb in its extracellular and transmembrane region, whereas in the cytoplasmic region it is identical (except for a single amino acid) to hFc7R IIa [14] . Three different iso forms of hFc7RIIb have been described, that result from alternative splicing. hFc7R IIb2 and hFc7 R IIb 3 differ only in the signal sequence, whereas hFc7R IIb l differs from hFc7 RIIb2 by a 19-amino acid insertion in the cytoplasmic tail [13] . hFc7RIIa occurs in two allelic forms, and is respon sible for the polymorphism in binding of m lg G l to human monocytes [5, 6] ,
We have now employed EBV-transformed B cells obtained from mIgG2b-HR or mIgG2b-LR to analyse, at the D N A level, whether hFc7RIIa or another isoform of I1FC7RII is responsible for the polymorphic binding of mIgG2b. We have previously reported that EBV-transformed cells from mIgG2b-HR can provide, just like monocytes, accessory cell function in the mitogenic response to m !gG 2b anti-CD3 MoAb [9] . The presence on EBV-transformed cells of the polymorphic Fc receptor responsible for the binding of m!gG2b could be confirmed by EA-rosetting [9] . Whereas monocytes express both I1FC7RII and hFc7 RI (and some times also hFc7 RIII), EBV-transformed cells do not express hFc7 RI or I1FC7RIII and therefore provide an excellent model to study the role of I1FC7 RII with respect to the mIgG2b. polymorphism. Furthermore, it was difficult to obtain sufficient numbers of highly purified monocytes or B cells from the few mIgG2b-HR available. We therefore decided to use only EBV-transformed B cells in the present study.
M A T E R IA L S AND M E T H O D S
Cells. Leucocytes were obtained by cytapheresis from healthy donors, and peripheral blood mononuclear cells (PBMC) were isolated by centrifugation on Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden). Monocytes were purified from PBMC by coun terflow centrifugation [15] and were > 90% pure, as judged by staining with May-Grturwald-Giemsa and nonspecific esterase. They were cryopreserved [16] until use. We have demonstrated before that cryopreserved mononuclear cells or monocytes still dis play the mIgG2b polymorphism [9] , EBV-transformed B-cells were obtained from mIgG2b~HR or mIgG2b-LR individuals [9] , and were cultured in RPMI-1640 medium containing both Hepes and sodium bicarbonate (ICN Biomedicals, Costa Mesa, CA, USA), supplemented with 10% heat inactivated FCS (Hyclone, Logan, UT, USA), 2 him glutamine, ImM sodium pyruvate, 50/ig ml-1 streptomycin, and 50 IU mP1 penicillin.
Oligonucleotides. All oligonucleotides were selected from the nucleotide sequences as published by Brooks et al [13] (hFc7RIIbl: Genbank M31935; hFc7RIIa: Genbank M31932), and nucleotides are numbered according to this reference. With respect to hFc7RIIb, [13] ) except for P52, that is specific for I1FC7RIIA. Oligonucleotides BECFII-3, BECint, and BCPII-3 are antisense and correspond to the reverse complement of the indicated nt sequences. [17] [18] [19] [20] have published a virtually identical sequence with one exception: in contrast to Brooks et al. they all report the sequence G-C (not C-G) at nucleotide positions 980-981, and therefore we have assumed that this is the correct sequence at these positions.
The sequences for all oligonucleotides are given in Table L In order to identify the l1Fc7R.II isoform distribution of EBV-B cell lines, a partial sequence of hFc7R.II was amplified using two primers that do not distinguish between the different isoforms of I1FC7RII: P63 [21] , that anneals in the extracellular region, and BECFII-3 annealing in the transmembrane region. Subsequent hybridization of amplified DNA on Southern blots was then performed either with the hFc7RIIa-specific oligonucleotide probe P52 [21] , or with BEC-3int that anneals to the extracellular part of all isoforms of hFc7RII.
F or amplification of RNA coding for the complete extracellular p art of I1FC7RII, we used a primer set consisting of BECFII-5 annealing at the upstream end of the extracellular domain, and BECFII-3 (described above). These primers do not discriminate between the different isoforms of I1FC7RII. For subsequent sequen cing, two internal oligonucleotides were selected: BEC-5int, and BEC-3int (described above).
The cytoplasmic region of I1FC7RIIB was amplified using a sense primer BCPII-5 (annealing in the transmembrane region of I1FC7RIIB), and an antisense primer BCPII-3 annealing in the untranslated part of the cytoplasmic region. For the sequencing of this comparatively short stretch of nucleotides, one internal oligo nucleotide was sufficient: BCP-5int (corresponding to a sequence in the transmembrane region of I1FC7RIIB).
All oligonucleotides were purified by reversed phase HPLC, Optimal annealing temperatures were empirically determined; ampli fication primer set BECFII-5/BECFII-3: 60°C; primer set BCPII-5/ BCPII-3: 52°C; primer set P63/BECFII-3: 56°C; all sequencing primers (BEC-5int, BEC-3int, and BCP-5int): 60°C; hybridization probe P52: 53°C; and hybridization probe BEC-3int: 63°C, Oligonucleotides were radiolabelled by phosphorylation in a 20 p\ reaction volume containing 25-50pmoi oligonucleotide, 2 (A lOx kinase buffer (500 m u Tris-HCl pH 7.5,100 mM MgCl2, 50 mM DTT, lm M spermidine), 5-10/xl 32P-7ATP (3000 Ci/mmol, Amersham International, Amersham, UK) and 1 fA T4 polynucleotide kinase (10 U Pharmacia Biotech, Uppsala, Sweden) for 45 min at 37°C and 10 min at 68°C.
Labelled probes were purified by spin column centrifugation (G-25 superfine DNA grade, Pharmacia Biotech, Uppsala, Sweden; 1 ml equilibrated in 0.1 x STE) using four elution volumes of 100^1 OJ x STE.
RNA isolation and PCR. Total cellular RNA was isolated from EBV-cells, monocytes, or cell lines U937, K562, Daudi and Raji, using the guanidine thiocyanate method [22] , concentrated by etha nol precipitation, and stored at -70°C until use. Subsequent amplification of acquired cDNA was performed in a thermal cycler (Perkin Elmer, Norwalk, CT, USA) after adding 80 (A o f a PCR mixture, containing 30pmol upstream primer, 10¡A lOx PCR buffer (500 mM KCI, 200mM Tris-HCl pH 8.4, 15mM MgCl2, 1 mg ml" 1 BSA) and 1.5 U Taq polymerase (Life Technologies Inc., Gaitersburg, MD, USA) using an amplification protocol consisting of 5 min template denaturation at 94°C, 30 cycles for I min at 94°C, 1 min at the primerset optimal annealing temperature and 1.5 min at 72°C, followed by a terminal extension step for 10 min at 72°C.
For additional reamplification, 1 /A of PCR product was added to 99 fA PCR mixture, containing 30pmol of each primer, 0.125mM dNTP, 10/il lOx PCR buffer, L5 U Taq polymerase and (when radiolabelled products were required) supplemented with P-adCTP (3000 Ci/mmol, Amersham International, Amersham, UK). Reamplification was performed using the amplification proto col described above.
Single strand conformation polymorphism. Radiolabelled PCR products diluted 1:5 in SSCP loading buffer (20mM EDTA pH 8.0, 20 mM NaOH, 0.05% xylene cyanol, 0.05% bromophenol blue in 96% formamide) were heated for 3 min at 85°C and kept at 0°C for 10 min. Two fA treated samples were loaded on a polyacrylamide gel (6%, 49:1, optional 0-10% glycerol, in lx TBE), separated at constant power (2 W) and gels were exposed to Kodak X-OMAT S film. In some experiments the PCR products were cleaved into two smaller fragments by adding 1 ¡A restriction enzyme Bgll (Life Technologies Inc., Gaitersburg, MD, USA) and 2 ¡A lOx reaction buffer (500 mM Tris-HCl pH 8.0, 100 mM MgCl2, 500 mM NaCl) and incubating for 60 min at 37°C.
Non-denaturating polyacrylamide gel electrophoresis. In order to separate the two hFc7RIIB cytoplasmic region isoforms (bl and b2), 5^il radiolabelled PCR products diluted 1:5 in TBE loading buffer (15% ficoll, 0.25% xylene cyanol, 0.25% bromophenol blue in lx TBE) were loaded on low-crosslinker polyacrylamidegel (6%, 49:1 in lx TBE buffer). The gel was analysed by autoradiography and segments containing DNA bands of interest were cut out, dsDNA was extracted by adding 100 pi Tris-HCl pH 8.0, Imw EDTA incubating for 15 min at 80°C and 16 h at 4°C.
Hybridization analysis o f PCR products. PCR products were analysed by separation on 2% (wt/vol) agarose and stained by ethidium bromide. Southern blotting was performed by transferring DNA to Hybond-N + (Amersham International, Amersham, UK) in 0.4m NaOH, 25mM EDTA. Membranes were washed (2x SSC) and incubated in 30 ml Standard Hybridisation mix [21] (5x SSC, 0.1% laurylsarcosine, 0.02% SDS 1% Blocking Reagent (Boehringer-Mannheim, Mannheim, Germany) for 1.5 h at the optimal annealing temperature. After adding 25pmol hybridization probe incubation was continued for 2 h at the same temperature followed by a washing procedure at stringency of 2x SSC, 0.1% SDS, twice at room temperature (20°C) and twice at the hybridization temperature. Blots were analysed after autoradiography using intensifying screens.
Sequence analysis. Prior to their use as templates in sequence analysis, PCR products were purified by the Wizzard PCR Preps DNA Purification System (Promega Corporation, Madison, WI, USA) according to the manufacturer's description. They were then applied as template in the Sanger dideoxynucleotide termination sequencing method [23] . In brief, a 7.5¡A aliquot of a mixture, containing 10 ¡A purified template, 11 fA sequencing PCR buffer (30mM Tris-HCl pH 9.0, 5 him MgCl2, 30mM KCI, 0.025% NP-40, 0.025% Tween-20), 10^1 32P labelled sequencing oligonucleotide (2.5pmol in O.lx STE) and 0.5pi Taq polymerase (5 U fiV 1) was added to 2.5 pi of the four termination mixes individually containing 160 fiM ddGTP, 80 ¡am dNTP; 1.28 mM ddATP, 40/¿m dNTP; 1.92 him ddTTP, 40 /zm dNTP; 640 ¿am ddCTP, 40 ¿¿m dNTP ail diluted in sequencing PCR buffer and overlaid with 20 /¿I mineral oil. Sequencing reaction was performed according to the amplification protocol described above for 15 cycles. Reaction products were dispensed in 10 ¿¿I sequencing loading buffer (20 fxM EDTA pH 8,0, 0.05% xylene cyanol, 0.05% bromophenol blue, 91% formamide), heated for 4 min at 94°C before loading 3 ¡j\ on polyacrylamide gel (7%, optional 6 % , 24:1,7 m urea in 0.5x TBE). After separation and autoradiography the sequences were analysed*
R E S U L T S hFc'yRIIB but not fiFc^RIIA is present in EBV-transform ed B cells
RNA was isolated from EBV-transformed B cells of either mIgG2b-HR or mIgG2b-LR individuals, and R N A coding for the extracellular part of hFc7 RII was amplified by RT-PCR using primers that do not discriminate between the different isoforms. The RT-PCR products from the EBVtransformed cells hybridized with a probe recognizing both the hFc7RIIA and hFc7 RIIB isoforms, but did not hybridize with an hFc7RIIA-specific probe (Fig. 1) . Hybridization with the hFc7 RIIA-specific probe was observed with RT-PCR products obtained from monocytes, from cell lines U937 and K562 and, very weakly, B cell line Daudi, and was not detectable with B cell line Raji. W e conclude that hFc7 RIIB but not hFc7 RIIA is present in the EBV-transformed cells (regardless whether they originate from m IgG 2b-H R or LR individuals).
Single strand conformation polymorphism ( S S C P ) analysis o f hFc^RIJB
We then focused on a more detailed analysis of I1FC7RIIB obtained from the EBV-transformed cells, and investigated whether there was a polymorphism detectable at the DNA level. Our first approach was SSCP analysis, which may detect allelic forms of DNA. We found no indications for allelism of I1FC7RIIB, not even when (after cleavage by restriction enzymes) shorter stretches of D N A were analysed.
Sequencing o f hFc^RIJB
Since SSCP analysis can reveal allelic differences but the absence of detectable differences is not conclusive, we decided to sequence the extracellular part of hFc7 RIIB. As shown in Table 2 , this sequence was completely identical for mIgG2b-H R and m!gG2b-LR individuals. The same sequence was found in a total of four high-responders and three lowresponders.
Whereas the extracellular part of the receptor is responsible for ligand binding, the cytoplasmic tail is involved in signal transduction (as discussed below), and therefore it was con ceivable that a difference in the sequence of the intracellular part of the receptor would affect its biological effects, There fore we also sequenced the intracellular part of I1FC7 RIIB. We found that both the hFc7 R IIbl and the hFc7RIIb2 isoform were present (bl containing a 57-nucleotide insert when compared with b2). Again, we found no sequence differences when RT-PCR products from four mIgG2b-HR and three m!gG2b-LR were analysed (data not shown). RNA coding for the extracellular part of I1FC7RII was amplified by RT-PCR using a primer set that does not discriminate between hFc7RIIa or hFc7RIIb. After Southern blotting, hybridization was performed with a probe specific for hFc7RIIa (panel a), or a probe that recognizes both hFc7RIIa and hFc7RIIb (panel b). Lane 1: no DNA. Lanes 2-5: cell lines U937, K562, Daudi, and Raji, respectively. Lane 6: monocytes of mIgG2b high-responder. Lanes 7-9: EBV-transformed cells from three mIgG2b high-responders. Lanes 10-12: EBV-transformed cells from three m!gG2b low-responders.
We have previously reported that mIgG2b can bind in a polymorphic way to human mononuclear cells. The presence of an Fc receptor that can interact with mIgG2b could also be demonstrated on EBV-transformed cells from mIgG2b-HR [9] . These EBV-transformed cells had the phenotype of B cells, and they did not express I1FC7 RI or I1FC7RIIL In immunofluorescence studies, staining was seen with MoAb KB61 but not M oAb IV.3 [9] . KB61 recognizes the hFc7RIIb isoform present on B cells, whereas IV.3 primarily binds to hFc7 R IIa that is expressed on monocytes and granulocytes [24] . An isoform of I1FC7 RII is responsible for the polymorphic binding of m lg G l, and it has been suggested that I1FC7 RII is responsible for binding of m IgG2b [12] . In functional studies, however, we found no evidence for an involvement of I1FC7 RII in the polymorphic binding of mIgG2b. MoAbs against I1FC7R II (including KB61) did not inhibit mIgG2b anti-CD3 induced T cell proliferation [9] . Furthermore, pro teolytic enzymes strongly reduced the expression of hFc7RII on EBV-transformed cells, whereas they caused an increased binding of mIgG2b in EA-rosetting [11] . Although these findings argue against the hypothesis that the polymorphic Nucleotide sequence of the extracellular part of hFc7RIIb in EBV-transformed B cells is identical formIgC2b high-responders and low-responders. After amplification by RT-PCR, sequencing was carried out by the Sanger method. The same sequence was found in a total of four mIgG2b-HR and three m!gG2b-LR.
binding of mIgG2b is caused by a polymorphic isoform of isoforms at R N A level. Sartnay et al. have studied isoform h F c 7RII, we felt that only an analysis at the D N A level (by sequencing) could yield definitive conclusions. Furthermore, expression in resting and activated B cells. In resting B cells, hFc7 R IIb2 was the predom inant isoform, although b y performing RT-PCR with primers that correspond to hFc7 R IIbl and (at a low level) hFc7 R IIa were also present, conserved sequences present in all identified isoforms of U pon activation the expression o f hFc7 RIIbl increased, h F c7 RII> there was the possibility that we might identify whereas hFc7 R IIb2 and hF c7RIIa decreased [25] . As we another very homologous but polymorphic isoform of reported before, the EBV-transformed cells have a high h F c7RII in the EBV-transformed cells.
expression of H L A -D R and transferrin receptor, and in this Our hybridization and sequencing experiments revealed respect they resemble activated rather than resting B cells [11] . th a t transcripts encoding for hFc7RIIbl and hFc7RIIb2, W ith respect to I1FC7 RIIA, we found abundant expression in b u t not for hFc7RIIa are present in EBV-transformed B monocytes and the cell lines U937 and K562. B cell line Daudi cells. The absence of an hFc7RIIa transcript is consistent expressed I1FC7 R IIA at a very low level, but in B cell line Raji with the absence of immunofluorescence staining with MoAb it was not detectable* These results with cell lines are very IV.3, that primarily recognizes this isoform [9] . To our similar to results obtained after Northern analysis [13] , knowledge EBV-transformed cells have not been analysed although others have reported expression of I1FC7RIIA in before with respect to the expression of different hFc7RII several B cell lines including Raji [25, 26] .
We could not detect allelic differences in hFc^RIIB between mIgG2b-HR and m IgG 2b-LR by the SSCP analysis. To ascertain that there are indeed no differences in sequence, we determined the nucleotide sequence in a total of seven EBV-transformed cell lines. The sequence for the extracellu lar part (Table 2 ) is exactly the same as reported by Brooks et al. [13] , except for an A instead of a T at position 564. Two other groups have also reported an A at the corresponding position [19, 20] . More importantly, the same nucleotide was found in both m IgG2b-HR and mIgG2b-LR. Since the primers used for sequencing the extracellular part of the receptor do not discriminate between hFcvRIIb and hFc7 RIIc, it is obvious that even in the case that hFc7RIIc would be expressed in these cells the nucleotide sequence would be identical for m IgG 2b-H R and m IgG 2b-LR.
Finally, we sequenced the intracellular region of hFc7RIIB. Studies on the corresponding murine Fc receptor have revealed that the cytoplasmic domain of the receptor determines its ability to endocytose immune complexes [27] . Similarly, the association of different isoforms of hFc7 RIIb with intracellular molecules and their biological function is determined by the cytoplasmic dom ain [28] . It was therefore conceivable that differences in EA-rosetting between H R and LR were caused by differences in the intracellular part of hFc7 RIIb. We found that both hFc7 R IIbl and hFc7RIIb2 were present in the EBV-transformed cells, but there were no differences in sequence between m IgG 2b-H R and mIgG2b-LR. The sequence we found was precisely the same as reported by Brooks et al. [13] , Identity of the nucleotide sequences predicts that the poly peptide chain of hFc7 R IIb is identical for m IgG 2b-H R and mIgG2b-LR. Our data cannot exclude the possibility that a difference in glycoprotein structure exists as a result of differences in glycosylation, although there are no experi mental data to support this possibility.
Recently, a polymorphism of the I1FC7R IIIA gene was identified [29] . Although in immunofluorescence experiments no evidence was found for expression of this receptor on EBV-transformed cells [9] , mononuclear cells from five mIgG2b~HR were genotyped for this I1FC7 R IIIA polymorph ism. However, no association with a particular I1FC7 RIIIA allele was found (M. de Haas, personal communication).
In conclusion, we found that both hFc7R IIbl and hFc7RIIb2 but not hFc7 RIIa are detectable in EBV-transformed B cells that bind mIgG2b. The hFc7R IIb isoforms do not display any sequence difference between m IgG2b-HR and mIgG2b-LR cells. Therefore we conclude that the poly morphic binding of mIgG2b to hum an B cells cannot be ascribed to one of the iso forms of I1FC7 RIL This conclusion is also supported by our previous studies on the effect of proteolytic enzymes on Fc receptor expression and function [11] , Furthermore, since there is no evidence that I1FC7R I or I1FC7 R III can be expressed on EBV-transformed B cells [9] , we must conclude that apparently a yet unidentified I1FC7 R different from hFc7RI, hFc7R II, or I1FC7 RIII is responsible for the polymorphic binding of mIgG2b to B cells. Although we did not perform a similar analysis with monocytes, it should be stressed that accessory cell function in mIgG2b anti-CD3 induced T cell proliferation can be provided by EBV-transformed B cells from mIgG2b-HR as adequately as by H R monocytes [9] . A recent study on the effects of human IgG2 on human B cells also concluded that these effects were mediated by a I1FC7R different from the three receptors identified so far [30] .
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